Group 1 - Hubei will add two new A-share listed companies this month: Wuhan Heyuan Biotechnology Co., Ltd. and Chaoying Electronics Circuit Co., Ltd. [1] - Heyuan Biotechnology has launched its subscription with an expected fundraising total of approximately 2.6 billion yuan, primarily for the construction of a recombinant human albumin industrialization base [1][2] - Heyuan Biotechnology was established in 2006 and has built an intelligent production line that meets international standards, capable of producing 12 million bottles of recombinant human albumin injection annually [1] Group 2 - Heyuan Biotechnology's IPO price is set at 29.06 yuan per share, with a total issuance of approximately 89.45 million shares, leading to a total post-issue share capital of 357.5 million shares [2] - Chaoying Electronics, founded in 2015, is a professional manufacturer of printed circuit boards (PCBs) [2] - Chaoying Electronics plans to use the funds raised from its IPO for two main projects: the second phase of its high-layer and HDI project and to supplement working capital and repay bank loans [2]
湖北新增两家A股上市公司
Chang Jiang Shang Bao·2025-10-23 23:57